Quick Takeaways
- David M. Mott has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $23,458,642.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David M. Mott
- Location
- Baltimore, MD
- Summary
- The estimated net worth of David M. Mott is at least $23,458,642 dollars as of 23 Feb 2026. David M. Mott is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $19.29M. David M. Mott is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. David M. Mott is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $703.6K.
- Signature
- /s/ Elizabeth Grammer, Attorney-in-Fact for David Mott
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David M. Mott and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ARDELYX, INC. ($19,285,738).
- Past-year value change for that position: +$5,349,528.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of David M. Mott
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ARDX | ARDELYX, INC. | Director | $19,285,738 | +$5,349,528 | +38% | 20 Feb 2026 |
| ELVN | IMARA Inc. | Director | $3,469,305 | 02 Jun 2022 | ||
| NVAX | NOVAVAX INC | Director | $703,599 | 20 Jun 2025 | ||
| MRSN | Mersana Therapeutics, Inc. | Director | $0 | 06 Jan 2026 | ||
| ADAP | Adaptimmune Therapeutics PLC | Director | 01 Jul 2024 | |||
| EPZM | Epizyme, Inc. | Director | 12 Aug 2022 |
Insider Transactions Reported by David M. Mott:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.